Clinical Trial Update: Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a low-dose combination of mycophenolate mofetil and tacrolimus for refractory lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Prograf (Tacrolimus)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Lupus Nephritis | Phase 4 | Status: COMPLETED